0000950170-24-070884.txt : 20240607 0000950170-24-070884.hdr.sgml : 20240607 20240607171742 ACCESSION NUMBER: 0000950170-24-070884 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rothenberg Mace CENTRAL INDEX KEY: 0001873988 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39485 FILM NUMBER: 241030694 MAIL ADDRESS: STREET 1: 171 OYSTER POINT BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tango Therapeutics, Inc. CENTRAL INDEX KEY: 0001819133 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 BROOKLINE AVENUE STREET 2: SUITE 901 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: (857) 320-4900 MAIL ADDRESS: STREET 1: 201 BROOKLINE AVENUE STREET 2: SUITE 901 CITY: BOSTON STATE: MA ZIP: 02215 FORMER COMPANY: FORMER CONFORMED NAME: BCTG Acquisition Corp. DATE OF NAME CHANGE: 20200723 4 1 ownership.xml 4 X0508 4 2024-06-05 0001819133 Tango Therapeutics, Inc. TNGX 0001873988 Rothenberg Mace C/O TANGO THERAPEUTICS, INC 201 BROOKLINE AVE., SUITE 901 BOSTON MA 02215 true false false false false Common Stock 2024-06-05 4 A false 6250 0.00 A 11250 D Stock Option (Right to Buy) 7.41 2024-06-05 4 A false 37500 0.00 A 2034-06-05 Common Stock 37500 37500 D These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in its entirety on the earlier of: (i) June 5, 2025 and (iii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year beginning on July 5, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. /s/ Douglas Barry, as attorney-in-fact 2024-06-07